Uncategorized
January 1, 2018
Naicons enters into a research collaboration with Rutgers University-New Brunswick for New Antibiotics: Efficient Microbial Extract Screening and Mutational De- Replication (TechAdvance). This collaboration continues the […]
November 1, 2017
NAICONS takes part in CARTNET (Combating Antimicrobial Resistance – a training network), a project funded by the European Union’s Horizon 2020 research and innovation programme under […]
June 15, 2017
NAICONS Team Discover New Antibiotic Effective against Drug-Resistant Bacteria. Scientists from Rutgers University-New Brunswick, NAICONS and elsewhere report in Cell today the discovery and mechanism of […]
April 18, 2017
NAICONS CEO to speak at ECCMID 2017 (Vienna 22nd – 25th April) read more>
January 16, 2017
NAICONS takes part in TOPCAPI (Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients), funded by the European Commission under the Horizon 2020, H2020-NMBP-BIO-2016 (no. 720793). For […]
January 5, 2017
NAICONS takes part in Rafts4Biotech (Synthetic bacterial lipid rafts to optimize industrial bioprocesses), funded by the European Commission under the Horizon 2020, H2020-NMBP-BIO-2016 (no. 720776) For […]
January 3, 2017
NAICONS takes part in Train2Target, an European Training Network funded by the European Commission under the Horizon 2020 Marie Skłodowska-Curie Action (no. 721484). The project, which […]
January 1, 2016
“NAICONS signs Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance ” read more>